These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25913641)

  • 1. Clinical trials in ulcerative colitis: a historical perspective.
    Hindryckx P; Baert F; Hart A; Magro F; Armuzzi A; Peyrin-Biroulet L;
    J Crohns Colitis; 2015 Jul; 9(7):580-8. PubMed ID: 25913641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolving primary and secondary endpoints in randomized controlled trials leading to approval of biologics and small molecules in IBD: an historical perspective.
    Allen PB; Bonovas S; Danese S; Peyrin-Biroulet L
    Expert Opin Biol Ther; 2020 Feb; 20(2):151-161. PubMed ID: 31815548
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trials in luminal Crohn's disease: a historical perspective.
    Hindryckx P; Baert F; Hart A; Armuzzi A; Panès J; Peyrin-Biroulet L;
    J Crohns Colitis; 2014 Nov; 8(11):1339-50. PubMed ID: 24841216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Definition and evaluation of mucosal healing in clinical practice.
    Mazzuoli S; Guglielmi FW; Antonelli E; Salemme M; Bassotti G; Villanacci V
    Dig Liver Dis; 2013 Dec; 45(12):969-77. PubMed ID: 23932331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of endoscopic assessment in ulcerative colitis in the era of infliximab.
    Daperno M; Sostegni R; Pera A; Rognone D; Rigazio C; Ercole E; Crocellà L; Lavagna A; Rocca R
    Dig Liver Dis; 2008 Jul; 40 Suppl 2():S220-4. PubMed ID: 18598992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Risk of Relapse in Ulcerative Colitis According to the Degree of Mucosal Healing (Mayo 0 vs 1): A Longitudinal Cohort Study.
    Barreiro-de Acosta M; Vallejo N; de la Iglesia D; Uribarri L; Bastón I; Ferreiro-Iglesias R; Lorenzo A; Domínguez-Muñoz JE
    J Crohns Colitis; 2016 Jan; 10(1):13-9. PubMed ID: 26351390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus for remission induction in ulcerative colitis: Mayo endoscopic subscore 0 and 1 predict long-term prognosis.
    Ikeya K; Sugimoto K; Kawasaki S; Iida T; Maruyama Y; Watanabe F; Hanai H
    Dig Liver Dis; 2015 May; 47(5):365-71. PubMed ID: 25682993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.
    Colombel JF; Rutgeerts P; Reinisch W; Esser D; Wang Y; Lang Y; Marano CW; Strauss R; Oddens BJ; Feagan BG; Hanauer SB; Lichtenstein GR; Present D; Sands BE; Sandborn WJ
    Gastroenterology; 2011 Oct; 141(4):1194-201. PubMed ID: 21723220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD.
    Molander P; Sipponen T; Kemppainen H; Jussila A; Blomster T; Koskela R; Nissinen M; Rautiainen H; Kuisma J; Kolho KL; Färkkilä M
    J Crohns Colitis; 2013 Oct; 7(9):730-5. PubMed ID: 23182163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis of the placebo rates of remission and response in clinical trials of active ulcerative colitis.
    Su C; Lewis JD; Goldberg B; Brensinger C; Lichtenstein GR
    Gastroenterology; 2007 Feb; 132(2):516-26. PubMed ID: 17258720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.
    Subramaniam K; Richardson A; Dodd J; Platten J; Shadbolt B; Pavli P
    Intern Med J; 2014 May; 44(5):464-70. PubMed ID: 24612209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of biologics in ulcerative colitis.
    Hanauer SB
    Dig Dis; 2010; 28(3):497-500. PubMed ID: 20926878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: rapid symptom resolution and improvements in quality of life.
    Probert CS; Dignass AU; Lindgren S; Oudkerk Pool M; Marteau P
    J Crohns Colitis; 2014 Mar; 8(3):200-7. PubMed ID: 24012063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic and clinical variables that predict sustained remission in children with ulcerative colitis treated with infliximab.
    Turner D; Griffiths AM; Veerman G; Johanns J; Damaraju L; Blank M; Hyams J
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1460-5. PubMed ID: 23672831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation Between Concentrations of Fecal Calprotectin and Outcomes of Patients With Ulcerative Colitis in a Phase 2 Trial.
    Sandborn WJ; Panés J; Zhang H; Yu D; Niezychowski W; Su C
    Gastroenterology; 2016 Jan; 150(1):96-102. PubMed ID: 26376350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal Healing in Ulcerative Colitis--When Zero is Better.
    Boal Carvalho P; Dias de Castro F; Rosa B; Moreira MJ; Cotter J
    J Crohns Colitis; 2016 Jan; 10(1):20-5. PubMed ID: 26438714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological healing: should it be considered as a new outcome for ulcerative colitis?
    Dal Buono A; Roda G; Argollo M; Peyrin-Biroulet L; Danese S
    Expert Opin Biol Ther; 2020 Apr; 20(4):407-412. PubMed ID: 31847610
    [No Abstract]   [Full Text] [Related]  

  • 18. Histological healing after infliximab induction therapy in children with ulcerative colitis.
    Wiernicka A; Szymanska S; Cielecka-Kuszyk J; Dadalski M; Kierkus J
    World J Gastroenterol; 2015 Oct; 21(37):10654-61. PubMed ID: 26457025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: defining remission in ulcerative colitis.
    Travis SP; Higgins PD; Orchard T; Van Der Woude CJ; Panaccione R; Bitton A; O'Morain C; Panés J; Sturm A; Reinisch W; Kamm MA; D'Haens G
    Aliment Pharmacol Ther; 2011 Jul; 34(2):113-24. PubMed ID: 21615435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized clinical trial of mesalazine suppository: the usefulness and problems of central review of evaluations of colonic mucosal findings.
    Kobayashi K; Hirai F; Naganuma M; Watanabe K; Ando T; Nakase H; Matsuoka K; Watanabe M
    J Crohns Colitis; 2014 Nov; 8(11):1444-53. PubMed ID: 24923656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.